Welcome to our dedicated page for McKesson news (Ticker: MCK), a resource for investors and traders seeking the latest updates and insights on McKesson stock.
McKesson Corporation (MCK) delivers vital healthcare supply chain solutions through pharmaceutical distribution, medical-surgical product management, and technology services. This page provides investors and industry observers with direct access to McKesson's official news updates and market-moving developments.
Track earnings announcements, strategic partnerships, and regulatory filings alongside operational milestones shaping McKesson's role in healthcare logistics. Our curated feed consolidates press releases and verified news to help stakeholders monitor the company's performance in pharmaceutical wholesale and healthcare IT innovation.
Discover updates on McKesson's supply chain optimization initiatives, technology platform enhancements, and collaborations with hospitals, pharmacies, and manufacturers. Bookmark this page for efficient monitoring of developments impacting one of North America's leading healthcare distribution networks.
The Board of Directors of McKesson Corporation (NYSE:MCK) has declared a regular dividend of 54 cents per share of common stock. This dividend will be payable on July 3, 2023, to stockholders recorded as of June 1, 2023. McKesson, a leader in healthcare services, focuses on improving health outcomes by partnering with various sectors including biopharma companies, care providers, and pharmacies. The company aims to enhance accessibility and affordability in healthcare, impacting numerous areas within the industry.
McKesson Corporation (NYSE: MCK) is set to release its fourth-quarter and full-year fiscal 2023 financial results after market close on Monday, May 8, 2023. A live webcast of the earnings conference call will be held at 4:30 PM Eastern Time to discuss the financial outcomes. Investors can access the webcast on McKesson’s Investor Relations website, where the earnings release and supporting materials will also be available. McKesson is a leader in healthcare services, dedicated to improving health outcomes and partnering with various stakeholders to enhance the accessibility and affordability of quality care.
McKesson Medical-Surgical Government Solutions LLC, based in Richmond, Va., has been awarded a five-year contract by the U.S. Department of Veterans Affairs for Federal Supply Schedule 65 II A. This contract allows greater access to McKesson’s medical supplies, including respiratory accessories and surgical instruments. According to Deborah Haywood, VP of Government Solutions, this milestone enhances McKesson’s ability to positively impact patient outcomes and create cost efficiencies in healthcare. The inclusion on the FSS facilitates expansion in providing high-quality medical supplies to federal customers, especially for veterans and the military community.
McKesson Corporation (NYSE: MCK) has announced its financial results for the third quarter of fiscal 2023. The detailed results are accessible on McKesson's Investor Relations website. A live webcast to discuss these results is scheduled for February 1st at 4:30 PM ET. McKesson is recognized as a leader in healthcare services, focusing on enhancing health outcomes through partnerships with various stakeholders, including biopharma companies and care providers. For additional insights about the company's impact in healthcare, visit McKesson.com.
The Board of Directors of McKesson Corporation (NYSE:MCK) declared a regular dividend of 54 cents per share of common stock. This dividend will be payable on April 3, 2023, to stockholders of record as of March 1, 2023. McKesson is a leader in diversified healthcare services, committed to enhancing health outcomes by collaborating with various stakeholders in the healthcare ecosystem.
FAQ
What is the current stock price of McKesson (MCK)?
What is the market cap of McKesson (MCK)?
